×
About 25,744 results

ALLMedicine™ Respiratory Failure Center

Research & Reviews  12,709 results

Initial emergency department mechanical ventilation strategies for COVID-19 hypoxemic r...
https://doi.org/10.1016/j.ajem.2020.06.082
The American Journal of Emergency Medicine; Lentz S, Roginski MA et. al.

Oct 19th, 2020 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging viral pathogen that causes the novel coronavirus disease of 2019 (COVID-19) and may result in hypoxemic respiratory failure necessitating invasive mechanical ventilation i...

Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars...
https://doi.org/10.1177/1753466620963016
Therapeutic Advances in Respiratory Disease; Procopio G, Cancelliere A et. al.

Oct 19th, 2020 - The worldwide spread of coronavirus disease 2019 (COVID-19), caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared a pandemic by the World Health Organization (WHO) in March 2020. According to clinical studie...

Cerebral venous thrombosis in COVID-19-associated coagulopathy: A case report.
https://doi.org/10.1016/j.jocn.2020.07.038
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia; Sugiyama Y, Tsuchiya T et. al.

Oct 19th, 2020 - COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was first reported in Wuhan, China in December 2019, and is ongoing pandemic. While a majority of patients with SARS-CoV-2 infection shows asymptomatic or mi...

Cardiovascular management following hypoxic-ischemic encephalopathy in North America: n...
https://doi.org/10.1038/s41390-020-01205-8
Pediatric Research; Giesinger RE, Levy PT et. al.

Oct 18th, 2020 - Hypotension and hypoxemic respiratory failure are common among neonates with hypoxic-ischemic encephalopathy (HIE) undergoing therapeutic hypothermia (TH). Right ventricular (RV) dysfunction is associated with adverse neurodevelopment. Individuali...

Noninvasive ventilation for acute hypoxemic respiratory failure in patients with COVID-19.
https://doi.org/10.1016/j.ajem.2020.09.075
The American Journal of Emergency Medicine; Avdeev SN, Yaroshetskiy AI et. al.

Oct 17th, 2020 - Noninvasive ventilation (NIV) is known to reduce intubation in patients with acute hypoxemic respiratory failure (AHRF). We aimed to assess the outcomes of NIV application in COVID-19 patients with AHRF. In this retrospective cohort study, patient...

see more →

Guidelines  43 results

Position Paper for the State-of-the-Art Application of Respiratory Support in Patients ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360514
Respiration; International Review of Thoracic Diseases; Pfeifer M, Ewig S et. al.

Jun 21st, 2020 - Against the background of the pandemic caused by infection with the SARS-CoV-2 virus, the German Respiratory Society has appointed experts to develop therapy strategies for COVID-19 patients with acute respiratory failure (ARF). Here we present ke...

Use of Tracheostomy During the COVID-19 Pandemic: American College of Chest Physicians/...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274948
Chest Lamb CR, Desai NR et. al.

Jun 8th, 2020 - The role of tracheostomy during the coronavirus disease 2019 (COVID-19) pandemic remains unknown. The goal of this consensus statement is to examine the current evidence for performing tracheostomy in patients with respiratory failure from COVID-1...

Consensus-Based Care Recommendations for Pulmonologists Treating Adults with Myotonic D...
https://doi.org/10.1159/000505634
Respiration; International Review of Thoracic Diseases; Boentert M, Cao M et. al.

Apr 16th, 2020 - Myotonic dystrophy type 1 (DM1) is a severe, progressive genetic disease that affects approximately 1 in 2,500 individuals globally [Ashizawa et al.: Neurol Clin Pract 2018;8(6):507-20]. In patients with DM1, respiratory muscle weakness frequently...

Acute subglottic laryngitis. Etiology, epidemiology, pathogenesis and clinical picture.
https://doi.org/10.5603/ARM.2019.0056
Advances in Respiratory Medicine; Mazurek H, Bręborowicz A et. al.

Nov 4th, 2019 - In about 3% of children, viral infections of the airways that develop in early childhood lead to narrowing of the laryngeal lumen in the subglottic region resulting in symptoms such as hoarseness, abarking cough, stridor, and dyspnea. These infect...

Predicting the Risk of Postoperative Pulmonary Complications
https://www.aafp.org/afp/2019/1015/p499.html
American Family Physician;

Oct 14th, 2019 - The incidence of pulmonary complications following major surgery is estimated to be 1% to 23%, with the risk varying based on patient factors and the type of surgery.1 Postoperative pulmonary complications include pneumonia, tracheobronchitis, pul...

see more →

Drugs  4 results see all →

Clinicaltrials.gov  12,787 results

Initial emergency department mechanical ventilation strategies for COVID-19 hypoxemic r...
https://doi.org/10.1016/j.ajem.2020.06.082
The American Journal of Emergency Medicine; Lentz S, Roginski MA et. al.

Oct 19th, 2020 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging viral pathogen that causes the novel coronavirus disease of 2019 (COVID-19) and may result in hypoxemic respiratory failure necessitating invasive mechanical ventilation i...

Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars...
https://doi.org/10.1177/1753466620963016
Therapeutic Advances in Respiratory Disease; Procopio G, Cancelliere A et. al.

Oct 19th, 2020 - The worldwide spread of coronavirus disease 2019 (COVID-19), caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared a pandemic by the World Health Organization (WHO) in March 2020. According to clinical studie...

Cerebral venous thrombosis in COVID-19-associated coagulopathy: A case report.
https://doi.org/10.1016/j.jocn.2020.07.038
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia; Sugiyama Y, Tsuchiya T et. al.

Oct 19th, 2020 - COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was first reported in Wuhan, China in December 2019, and is ongoing pandemic. While a majority of patients with SARS-CoV-2 infection shows asymptomatic or mi...

Cardiovascular management following hypoxic-ischemic encephalopathy in North America: n...
https://doi.org/10.1038/s41390-020-01205-8
Pediatric Research; Giesinger RE, Levy PT et. al.

Oct 18th, 2020 - Hypotension and hypoxemic respiratory failure are common among neonates with hypoxic-ischemic encephalopathy (HIE) undergoing therapeutic hypothermia (TH). Right ventricular (RV) dysfunction is associated with adverse neurodevelopment. Individuali...

Noninvasive ventilation for acute hypoxemic respiratory failure in patients with COVID-19.
https://doi.org/10.1016/j.ajem.2020.09.075
The American Journal of Emergency Medicine; Avdeev SN, Yaroshetskiy AI et. al.

Oct 17th, 2020 - Noninvasive ventilation (NIV) is known to reduce intubation in patients with acute hypoxemic respiratory failure (AHRF). We aimed to assess the outcomes of NIV application in COVID-19 patients with AHRF. In this retrospective cohort study, patient...

see more →

News  197 results

UK doctors to trial ibuprofen in COVID-19 patients with breathing difficulties
https://www.reuters.com/article/us-health-coronavirus-britain-ibuprofen/uk-doctors-to-trial-ibuprofen-in-covid-19-patients-with-breathing-difficulties-idUSKBN23A1DV

Jun 3rd, 2020 - LONDON (Reuters) - British doctors are trialling a formulation of anti-inflammatory ibuprofen to see if it reduces respiratory failure in patients with severe symptoms of COVID-19. The trial involves a particular formulation of ibuprofen, which re...

FDA to allow alternative respiratory devices to treat COVID-19
https://www.mdedge.com/internalmedicine/article/219591/coronavirus-updates/fda-allow-alternative-respiratory-devices-treat?channel=38029
Gregory Twachtman

Mar 25th, 2020 - The Food and Drug Administration identified a number of medical devices that can be used to help treat patients suffering from COVID-19 if ventilators are not available. “Whenever possible, health care facilities should use FDA-cleared conventiona.

Azerbaijan reports first coronavirus death
https://www.reuters.com/article/us-health-coronavirus-azerbaijan/azerbaijan-reports-first-coronavirus-death-idUSKBN20Z29V

Mar 12th, 2020 - BAKU (Reuters) - An Azeri woman who was quarantined after returning from Iran has died from coronavirus, Azerbaijan’s first death from the outbreak, the country’s emergency crisis center said on Thursday. The woman, who was born in 1969, was found...

Moldova reports first coronavirus case
https://www.reuters.com/article/us-health-coronavirus-moldova/moldova-reports-first-coronavirus-case-idUSKBN20V08U

Mar 8th, 2020 - CHISINAU (Reuters) - Moldova has reported its first confirmed coronavirus case, the Moldovan health ministry said late on Saturday. The 48-year-old woman was hospitalized on Saturday after she arrived from Italy, the ministry said in a statement. ...

FDA approves Givlaari for treatment of acute hepatic porphyria
https://www.mdedge.com/clinicalneurologynews/article/212845/anemia/fda-approves-givlaari-treatment-acute-hepatic-porphyria?channel=37225
Lucas Franki, Clinical Neurology News

Nov 21st, 2019 - The Food and Drug Administration has approved givosiran (Givlaari) for the treatment of adult patients with acute hepatic porphyria, a genetic disorder that causes buildup of porphyrin molecules. Wikimedia Commons/FitzColinGerald/ Creative Commons.

see more →

Patient Education  4 results see all →